Medical Conditions Found After Others Noticed Symptoms
"I know it's a common issue, but I had a friend say he thought I was depressed. I thought, I'm not sad, therefore I'm not depressed. It took me years after that comment to learn he was right and seek help. Now I'm happily on antidepressants and doing so much better than before."
—madds2016
"One of my friends posted about her recent Hashimoto's diagnosis and shared an infographic with a list of common symptoms. I ran down the list and found myself checking a lot of boxes. I went to my primary care doctor shortly after to have labs run, and sure enough, I had the exact same condition! That friend indirectly saved my life in a way."
"When I was in college, I mentioned to a teammate on my cross country team that I couldn't sleep because my mind would race — just so many thoughts that kept me up. She suggested I had ADHD. My twin brother has it, and it's genetic. He was diagnosed around age 6 or 7. I was 29."
"Now I'm medicated and sleep like a rock (mostly) every night."—madds2016
"Since I was a teen, I'd tell people I was allergic to the cold. My skin would get super itchy and come out in blotches and dry patches. Everyone laughed when I said I was allergic to a temperature. I'm 31 now. Two years ago, I went to the doctor for something unrelated. He saw the patches on my skin and immediately diagnosed me with psoriasis, an autoimmune skin disorder. And guess what? Cold temperatures make it worse."
"Hormonal dysfunction. I'm a woman who, since puberty, had severe acne and heavy periods — like changing a pad every two minutes. I also needed way more food to feel full. I went to a gynecologist at 15, but he said it was normal, so I believed him. When I was in my 30s, my mom saw my (very hairy) unshaven legs and said, 'THIS is not normal!' We ran tests. Turns out, I had way too much testosterone. For reference: Women's levels should be between 0.08 and 0.48. Mine was 0.54."
"I'm now on birth control and life has never been better. I never realized anything was wrong because it had always been that way — the periods, the hair, the acne, the appetite. I even thought I just didn't have a waistline. Nope, it was hormonal weight gain. I have one now."—mudda8139
"Autism. Everyone said my son was just like me when I was little. He had already received an autism diagnosis, so I had myself tested too — and I'm autistic as well."
"Ehlers-Danlos Syndrome! I had someone gently suggest that I get checked out (after years of unexplained symptoms) and boom, I was a textbook case."
"ADHD. I didn't know I had it until my daughter was diagnosed as a teenager. We were discussing her symptoms, and I realized, 'Hey, that sounds like me.'"
—abourque
"I thought everyone had TV static vision. Nope. Turns out I just have Visual Snow Syndrome. I figured it out when I randomly read an article about it, and I was like, 'Hey, wait a minute…' It was like the internet pointed it out to me."
"My wife and I did foster care for 10 years. When one of our foster kids came through with severe food insecurity issues, my wife explained all the signs we needed to watch for. As she went through the list, I realized I had all of those issues myself. My wife inadvertently diagnosed me with food insecurity from my childhood."
"I was having really bad back pain from an unrelated injury, and during an X-ray, the medical team noticed spots on my lungs. At first, they thought it was lung cancer, which scared the crap out of me. After a lung biopsy, the doctor showed me pictures of my bronchial tract and said, 'See all those white dots? That's supposed to be pink.' Without that observant radiologist spotting something completely unrelated to what I came in for, I might never have known I had sarcoidosis."
—abourque
"I always thought I was allergic to my own sweat and working out, since I would break into hives! I didn't know what was happening until a medical professional diagnosed me with spontaneous urticaria — an autoimmune issue where my body produces too much histamine. It turns out I'm triggered by sudden temperature changes, not sweat. If it's a really hot day and I jump into the ocean, I'll break out. If it's a cold day and I'm wearing a coat but my legs are exposed, my legs will break out! I have to get injections every month."
"When I was younger, I had some GI issues. The radiology reports showed my appendix was on the left side due to genetic malrotation of the colon. The doctor didn't bother telling me, but I overheard him tell his nurse. A few years later, I had pain on the left side and they suspected chronic appendicitis. But when they did surgery, the pathology reports showed my appendix had endometriosis."
"Many years ago, when I was experiencing severe migraines, I had several scans done on my head to rule out any internal cause. When the results came back, the doctor asked if I had ever hit my head and lost consciousness. I said no, not that I recall. Apparently, I must have had some kind of brain trauma I don't remember, because they explained that my right frontal lobe was atrophied. The migraines eventually went away on their own, but that doctor's observation about my brain explained a lot about my impulse control issues that I never understood before."
—christines442ed4b4e
"I had what they call 'silent' endometriosis. It's far from silent now, but I had absolutely no symptoms for years. I only found out because a surgeon discovered it unexpectedly when I went in for a completely unrelated procedure to get my tubes tied."
Have you ever discovered a medical condition after someone pointed out a symptom you didn't realize was unusual? Share your story in the comments below! And remember, if someone's ever pointed something out, or if something feels off to you, it's always worth asking questions. You never know what you might uncover.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
a day ago
- Time Business News
ADHD Treatment Success Rate: Strattera vs Adderall
Attention Deficit Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder affecting both children and adults. It is characterized by persistent patterns of inattention, impulsivity, and hyperactivity. Managing ADHD typically involves a combination of behavioral therapy, lifestyle changes, and medication. Two of the most commonly prescribed medications are Strattera vs adderall. While both aim to improve focus and reduce hyperactivity, they differ significantly in their mechanisms, side effects, and success rates. Understanding the success rate of each medication is essential for determining the best treatment approach for individuals with ADHD. When it comes to treating anxiety and depression, understanding how medications differ is essential. Two commonly prescribed SSRIs are Lexapro vs zoloft, each offering unique benefits depending on the individual's symptoms and response. While both help regulate serotonin levels in the brain, Lexapro is often preferred for its simplicity in dosing, whereas Zoloft may be more suitable for those dealing with panic disorder or OCD. Consulting with a healthcare provider can ensure the best fit based on medical history, side effects, and treatment goals. Personalized treatment is key to achieving long-term mental wellness and stability. Strattera is a non-stimulant medication that works by increasing the levels of norepinephrine in the brain. This neurotransmitter plays a role in regulating attention, impulse control, and activity levels. Strattera is often prescribed to individuals who do not respond well to stimulant medications or those who are at risk of substance misuse. Unlike stimulants, Strattera does not have an immediate effect. It usually takes several weeks for noticeable improvement in symptoms. Because it works gradually and has a different mechanism of action, it is sometimes preferred for individuals with coexisting conditions like anxiety. Adderall is a stimulant medication that increases the levels of dopamine and norepinephrine in the brain. It is widely recognized for its rapid onset of action, often improving attention and focus within 30 to 60 minutes of ingestion. Adderall is available in both immediate-release and extended-release forms, making it a flexible option for many patients. The stimulant nature of Adderall means it is typically more effective in managing core ADHD symptoms quickly. However, it also has a higher potential for abuse and side effects such as increased heart rate, insomnia, and anxiety. When evaluating success rates, it is important to consider both symptom improvement and patient tolerability. Clinical studies show that Adderall has a higher immediate response rate than Strattera. Approximately 70% to 80% of patients using Adderall report significant improvement in symptoms. In contrast, Strattera demonstrates success in about 50% to 60% of cases. However, these numbers vary based on individual differences, including age, severity of symptoms, and presence of comorbid conditions. Long-term effectiveness also plays a role in determining treatment success. Adderall's efficacy tends to remain stable over time, especially when dosage is carefully managed. However, some patients may develop tolerance, requiring dosage adjustments. Strattera, while slower to take effect, offers sustained symptom control for many patients over the long term. It is not associated with tolerance or dependence, making it a suitable option for extended use. For patients who experience side effects or diminishing response with Adderall, transitioning to Strattera may provide stable, long-term symptom management. Side effects are a critical factor in medication success. Adderall is known for causing appetite loss, insomnia, anxiety, and increased heart rate. For some, these side effects are intolerable and lead to discontinuation. In contrast, Strattera's side effects include nausea, fatigue, and dizziness, but it generally has a lower risk of causing anxiety or sleep problems. In practice, patients who are sensitive to stimulants may have a higher success rate with Strattera due to better tolerability, even if the symptom improvement is more gradual. The age of the patient also influences how well a medication works. In children, Adderall is frequently the first-line treatment due to its high efficacy and fast results. In adolescents and adults, both medications are used, but the choice often depends on individual lifestyle and health profile. Adults with ADHD who have a history of substance use or anxiety disorders may find Strattera to be a safer and more stable option. Therefore, age and personal medical history are essential considerations in choosing the right treatment. No single medication works for everyone with ADHD, and treatment success often requires a personalized approach. Physicians usually start with the most effective medication and monitor the patient closely. If the first medication does not work or causes side effects, they may switch to another. In many cases, patients may try both Adderall and Strattera at different times to determine which one offers better control with fewer side effects. Combining medication with behavioral therapy also significantly increases the overall success rate of ADHD treatment. In summary, Adderall tends to have a higher success rate for immediate symptom relief in ADHD, with around 70% to 80% of users experiencing improvement. Strattera has a moderate success rate of about 50% to 60%, but it offers a non-stimulant alternative with a lower risk of side effects and no potential for abuse. While Adderall may be more effective for rapid control, Strattera provides a safer long-term option for many individuals. Ultimately, the best medication depends on the individual's symptoms, medical history, and personal response. Working closely with a healthcare provider ensures the highest chance of treatment success. TIME BUSINESS NEWS
Atlantic
a day ago
- Atlantic
Nicotine Is in Unchartered Territory
For the better part of the past century, the case against nicotine was simple: Smoking a cigarette might feel nice, but it will eventually kill you. Nearly one in five deaths in the United States is caused by complications from cigarette smoke. Chewing tobacco is less dangerous, but still deadly: It has long been associated with head and neck cancers. But in 2025, nicotine isn't so straightforward. Smoking is so deadly not because of nicotine, per se, but because of tobacco: Lighting a cigarette burns tobacco, releasing nicotine into the body. Chewing tobacco entails gnawing on actual tobacco leaves. Nowadays, it's easier than ever to get a nicotine buzz without any tobacco at all: Just puff on a vape or pop a tiny nicotine pouch between your teeth and upper lip. These cigarette alternatives have been around for a while, but only recently have they gone fully mainstream. In January, the FDA officially sanctioned the sale of Zyn, among the most recognizable nicotine-pouch brands. In the past three months alone, Philip Morris International, which makes Zyn, shipped 190 million cans of the stuff to stores. And last month, the agency reversed a prior ruling and authorized Juul e-cigarettes. These products, the FDA has concluded, 'generally have lower health risks than cigarettes.' In this nicotine boom, it's easy to see the drug as harmless, even good for you. Ads that tout the benefits of nicotine are everywhere: Zyn, for example, has been marketed as an 'office essential' that also offers 'relaxation on-the-go.' Nicotine somehow feels both energizing and relaxing at the same time, kind of like the buzz of a vodka Red Bull. The drug has been linked to statistically significant improvements in a number of cognitive exercises. The marketing goes further: Joe Rogan has hawked Athletic Nicotine, a nicotine-pouch brand that claims the drug can serve as an 'exercise performance-enhancing tool.' Tucker Carlson—who has his own brand of nicotine pouches—recently claimed that because of nicotine, he is 'never sick.' But nicotine is not a wonder drug. The cognitive improvements found in studies were modest. Bethea AnnaLouise Kleykamp, an assistant professor of psychiatry at the University of Maryland who has studied nicotine, summed it up this way: The drug 'might be, if you were to subtract it from the smoke, something that could help some people,' such as those who are sleep-deprived or have a cognitive disorder like ADHD. Not exactly a ringing endorsement. Moreover, there's still a lot we don't know about what nicotine alone does to the body. All of this has nicotine in a strange place. Before the advent of newer products, the field of public health was united in its stance that no one should be using cigarettes, and thus nicotine. Now the message is more muddled than ever. Some public-health experts still suggest staying away from nicotine in and of itself. After the decades-long war against smoking, they see new products as Big Tobacco's latest gambit to hook the public. Others make a different calculation: If the health effects of nicotine alone are less concerning than those of cigarettes, what's so bad about an adult sucking on a Zyn? Presuming people recognize that these products 'may have some health risks,' Neal Benowitz, an emeritus professor of medicine at UC San Francisco, told me, 'I have no problem with that.' Such differing views stem from the unclear health effects of cigarette alternatives. Consuming nicotine via vape or pouch is surely safer than smoking a cigarette, but that isn't saying much. No researchers I spoke with gave nicotine an unequivocal endorsement. 'I would never go so far as to say that any drug is completely safe,' Jed Rose, an emeritus professor of psychiatry at Duke University who runs a research firm that has done paid research for nicotine companies, told me. 'Whether nicotine contributes in any way to other diseases associated with smoking is not as firmly resolved as people like to think.' Rose cited a study that showed nicotine accelerated tumor growth in mice. Other experts I spoke with cited data from Sweden demonstrating that smokeless products carry some cardiovascular risks. And emerging research indicates that the components inside of vapes can leach heavy metals into the mist that users inhale, potentially exposing them to increased cancer risk. For the most part, science simply hasn't answered the question of how bad nicotine alone is for you. Most of the studies on the bodily effects of nicotine have been completed using subjects who smoke. For now, the clearest problem with puffing on a Juul is that nicotine remains extremely addictive, whatever form it comes in. Addiction researchers have said that nicotine is just as difficult to quit as heroin. Smokeless products might be a little easier to quit than cigarettes, based on how they deliver nicotine. But it's reasonable to assume that these new products will also worsen the problem of nicotine addiction by making the drug easier to consume. Desk workers can pop nicotine pouches without having to step away for a smoke break. Vape clouds are more readily concealed than the stench of cigarette smoke. This is part of the appeal: Rogue, a Zyn competitor, advertises its product as a way to 'enjoy the nicotine you love without getting noticed, whether you're in a marathon of meetings, perfecting your meal-prep, or just can't step away for a smoke break.' (Rogue, like other nicotine brands, has to legally include warnings in its ads that its products are addictive.) The effects of an addiction alone are not typically a first-order concern in the world of public health. Addictions typically come with other, more pressing consequences: For cigarettes, it's heart attacks and cancer; for heroin, it's overdoses. Anyone who has seen photos of smokers hooked to oxygen or revealing their lung-cancer scars can attest that public health has become expert in warning potential victims of these types of health problems. The risks of a nicotine addiction without the smoke are murkier. 'There are interpersonal, intrapersonal, and economic consequences to being addicted,' Eric Donny, a neuroscience professor at Wake Forest University who studies nicotine, told me. 'It's really hard to quantify this in a way that we are used to.' Nicotine boosters have compared the drug to caffeine—which is also addictive, but generally not a problem. (Hence the Death Before Decaf shirts, tote bags, and even tattoos.) But research suggests that nicotine addiction is more intense than a caffeine dependency, potentially taking a bigger toll on people's lives. The financial costs alone can be onerous: Nicotine prices vary a lot from state to state, but in Washington, D.C., where I live, someone with an extreme Zyn habit may be shelling out upwards of $10 a day to feed their addiction. A Juul isn't much cheaper. With either product, a heavy user is likely to spend several thousands of dollars a year. Addiction can also take a psychological toll. Being hooked on nicotine means your brain is always screaming for another hit of the drug. At times, the longing can feel insatiable, and can force people to act in ways that are entirely against their own self-interest. A teen addicted to vaping might take a few puffs in the school bathroom, even if getting caught might mean a suspension. Or a longtime user may continue to pop nicotine pouches after a heart attack, despite research showing that quitting nicotine significantly reduces someone's risk of death. These downsides might seem minuscule compared with those of cigarettes. A rotting lung is considerably worse than a $10-a-day nicotine habit. But they shouldn't be ignored. If cigarette-smoking rates continue their decades-long drop, it's reasonable to assume that vaping and pouches will become the dominant ways people consume nicotine. New nicotine products might have solved the biggest problem with smoking. Many other, more subtle problems still remain.
Yahoo
2 days ago
- Yahoo
Instagram sisters raise neurodiversity awareness
Two sisters have been supporting people living with neurodiversity and helping educate others through their training company. Iveta Pudilova, 24, discovered she was neurodivergent after sister Vera was diagnosed with autism. "I grew up non-verbal. I couldn't speak until I was about five years old and even now I experience verbal shutdown. So verbal communication can be a really difficult challenge," Iveta said. In 2019, Vera started documenting her experiences through drawings and reflections on Instagram. Iveta helped and the Birmingham sisters went on to found the National Neurodiversity Training company last year. By May, the company had delivered neurodiversity training to seven organisations and 350 people, helping them to understand how to better support employees. Neurodivergence is an umbrella term that includes a number of conditions including autism spectrum disorder, attention-deficit hyperactivity disorder and dyslexia. Iveta said her sister Vera's Instagram reflections had not been intended to go viral, but her take on life gained unexpected traction. She explained her sister was "a very creative person" who made "content illustrations about her experience of being diagnosed... to connect with other autistic people". Iveta joined her and added: "We started an e-commerce [initiative], selling communication products like badges and cards, because a lot of neurodivergent people are non verbal." 'More productive' Badges and cards have helped neurodivergent people express themselves in public. One design reads: "I wear noise-cancelling headphones but I can still hear you." Iveta said they had started e-commerce work "to empower other neurodivergent people". However, she added "the lack of neurodiversity awareness and support is impacting everyone, including companies, and so we transitioned to delivering neurodiversity training". Their company now works with organisations including the NHS and is behind training delivered in tech firms, universities and local government. One project, in partnership with Birmingham Newman University and the NHS, involved training psychological and wellbeing practitioners to better support autistic patients. 'Looking to leave' "What we found is that neurodiverse teams are about 30% more productive when they have the right support," Iveta said. "But 50% of neurodivergent staff are... looking to leave their employer because of a lack of support." She said in the work with the NHS, they had addressed "diagnostic bias", which she explained was essentially when a practitioner diagnosing someone "might have personal biases". The company was invited to deliver staff training "on recognising their own biases, addressing them, but then also tailoring their therapy services and support to their autistic patients". Iveta added: "In the last year we've seen kind of the corporate world take up neurodiversity a lot more because there's more demand both internally, and [from] society pressures." Follow BBC Birmingham on BBC Sounds, Facebook, X and Instagram. More on this story The young entrepreneurs embracing neurodiversity 'Neurodiversity awareness growing in Guernsey' Neurodiversity Celebration Week 2025: What is it all about? Film about neurodivergency tackles 'assumptions' Related internet links National Neurodiversity Training
